These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Rapid identification and susceptibility to killer toxins of yeasts isolated from non-systemic mycoses]. Sangorrín MP; Lopes CA; Rivero A; Caballero AC Rev Argent Microbiol; 2007; 39(4):230-6. PubMed ID: 18390160 [TBL] [Abstract][Full Text] [Related]
23. Prevalence, species distribution and antifungal sensitivity of vaginal yeasts in infertile women. Verghese S; Padmaja P; Asha M; Elizabeth SJ; Anitha A; Kundavi KM; Jayanthi N; Varma T Indian J Pathol Microbiol; 2001 Jul; 44(3):313-4. PubMed ID: 12024920 [TBL] [Abstract][Full Text] [Related]
24. Antifungal susceptibility profiles of bloodstream yeast isolates by Sensititre YeastOne over nine years at a large Italian teaching hospital. Posteraro B; Spanu T; Fiori B; De Maio F; De Carolis E; Giaquinto A; Prete V; De Angelis G; Torelli R; D'Inzeo T; Vella A; De Luca A; Tumbarello M; Ricciardi W; Sanguinetti M Antimicrob Agents Chemother; 2015 Jul; 59(7):3944-55. PubMed ID: 25896705 [TBL] [Abstract][Full Text] [Related]
25. [Short communication: In vitro activity of amphotericin B with fluconazole or voriconazole combinations against Candida albicans isolates]. Oz Y; Akşit F; Kiraz N; Kiremitçi A Mikrobiyol Bul; 2008 Jan; 42(1):149-55. PubMed ID: 18444574 [TBL] [Abstract][Full Text] [Related]
26. Candida spp. in vitro susceptibility profile to four antifungal agents. Resistance surveillance study in Venezuelan strains. Panizo MM; Reviákina V; Dolande M; Selgrad S Med Mycol; 2009 Mar; 47(2):137-43. PubMed ID: 18651308 [TBL] [Abstract][Full Text] [Related]
27. [In vitro biofilm formation and relationship with antifungal resistance of Candida spp. isolated from vaginal and intrauterine device string samples of women with vaginal complaints]. Calışkan S; Keçeli Özcan S; Cınar S; Corakçı A; Calışkan E Mikrobiyol Bul; 2011 Oct; 45(4):697-706. PubMed ID: 22090300 [TBL] [Abstract][Full Text] [Related]
29. Antifungal susceptibilities of Candida species isolated from the patients with vaginal candidiasis. Nagashima M; Yamagishi Y; Mikamo H J Infect Chemother; 2016 Feb; 22(2):124-6. PubMed ID: 26627336 [TBL] [Abstract][Full Text] [Related]
30. High prevalence of non-albicans yeasts and detection of anti-fungal resistance in the oral flora of patients with advanced cancer. Bagg J; Sweeney MP; Lewis MA; Jackson MS; Coleman D; Al MA; Baxter W; McEndrick S; McHugh S Palliat Med; 2003 Sep; 17(6):477-81. PubMed ID: 14526879 [TBL] [Abstract][Full Text] [Related]
31. Vulvovaginal candidiasis is associated with the production of germ tubes by Candida albicans. Consolaro ME; Albertoni TA; Svidzinski AE; Peralta RM; Svidzinski TI Mycopathologia; 2005 Jun; 159(4):501-7. PubMed ID: 15983735 [TBL] [Abstract][Full Text] [Related]
32. Efficacy of fluconazole and nystatin in the treatment of vaginal Candida species. Martins HP; da Silva MC; Paiva LC; Svidzinski TI; Consolaro ME Acta Derm Venereol; 2012 Jan; 92(1):78-82. PubMed ID: 21918792 [TBL] [Abstract][Full Text] [Related]
33. Antifungal drug resistance in pathogenic fungi. Vanden Bossche H; Dromer F; Improvisi I; Lozano-Chiu M; Rex JH; Sanglard D Med Mycol; 1998; 36 Suppl 1():119-28. PubMed ID: 9988500 [TBL] [Abstract][Full Text] [Related]
34. Candida species and C. albicans biotypes in women attending clinics in genitourinary medicine. Odds FC; Webster CE; Fisk PG; Riley VC; Mayuranathan P; Simmons PD J Med Microbiol; 1989 May; 29(1):51-4. PubMed ID: 2657069 [TBL] [Abstract][Full Text] [Related]
35. [Vulvovaginal candidiasis and sensitivity of pathogens to antimycotics]. Sojáková M; Liptajová D; Simoncicová M; Borovský M; Subík J Ceska Gynekol; 2003 Jan; 68(1):24-9. PubMed ID: 12708111 [TBL] [Abstract][Full Text] [Related]
36. Epidemiological phenotypic characteristics of vaginal yeasts at the Comoros. Farina C; Saleri N; Lombart JP; Toyb M; Youssouf Z; Caligaris S; Matteelli A Mycoses; 2009 Sep; 52(5):458-61. PubMed ID: 18983428 [TBL] [Abstract][Full Text] [Related]
37. Correlation between antifungal resistance and virulence factors in Candida albicans recovered from vaginal specimens. El-Houssaini HH; Elnabawy OM; Nasser HA; Elkhatib WF Microb Pathog; 2019 Mar; 128():13-19. PubMed ID: 30562603 [TBL] [Abstract][Full Text] [Related]
38. Incidence and distribution of vaginal yeasts in Malaysian women. Ngeow YF; Soo-Hoo TS Mycoses; 1989 Nov; 32(11):563-7. PubMed ID: 2615779 [TBL] [Abstract][Full Text] [Related]
39. Therapeutic efficacy of posaconazole against isolates of Candida albicans with different susceptibilities to fluconazole in a vaginal model. González GM; Robledo E; Saldívar D; González G; Bosques F; Garza E Med Mycol; 2007 May; 45(3):221-4. PubMed ID: 17464843 [TBL] [Abstract][Full Text] [Related]
40. [Prevalence of Candida albicans and Candida non-albicans in clinical samples during 1999-2001]. Mujica MT; Finquelievich JL; Jewtuchowicz V; Iovannitti CA Rev Argent Microbiol; 2004; 36(3):107-12. PubMed ID: 15559191 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]